MNKD
MANNKIND CORP
Company overview
- Market capitalization
- $1.08B
- Employees
- 591
- Latest publication
- 2026-09-29
About MANNKIND CORP
MannKind Corporation, a biopharmaceutical company, focuses on the provision of various solutions for transforming chronic disease care. It develops and commercializes treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease. It offers Afrezza inhalation powder, an inhaled insulin used to improve glycemic control in adults with diabetes; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults. Its products also include Tyvaso DPI for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; FUROSCIX, a furosemide injection to treat fluid buildup in patients with chronic heart failure or chronic kidney disease. The company's pipeline of treatments for orphan lung diseases include MNKD-201, a dry-powder formulation of nintedanib for the treatment of idiopathic pulmonary fibrosis and MNKD-701. It has collaboration and license agreement with United Therapeutics Corporation for development, regulatory, and commercial activities of Tyvaso DPI; and collaboration agreement with Thirona to evaluate the therapeutic for the treatment of pulmonary fibrosis. MannKind Corporation was incorporated in 1991 and is headquartered in Danbury, Connecticut.
Financial statements
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20122012-12-31 · USD | FY 20102010-12-31 · USD | FY 20082008-12-31 · USD | FY 20072007-12-31 · USD | FY 20062006-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 348,966,000USD | 285,504,000USD | 198,962,000USD | 35,000USD | 93,000USD | 20,000USD | 10,000USD | 100,000USD |
| Cost Of Revenue | 61,160,000USD | 76,602,000USD | 62,771,000USD | 127,570,000USD | 136,091,000USD | 293,526,000USD | 293,267,000USD | 225,280,000USD |
| Gross Profit | 287,806,000USD | 208,902,000USD | 136,191,000USD | 35,000USD | 93,000USD | 20,000USD | 10,000USD | 100,000USD |
| Research Development | 66,348,000USD | 45,893,000USD | 31,283,000USD | 101,522,000USD | 112,279,000USD | 250,442,000USD | 256,844,000USD | 191,796,000USD |
| Selling General Administrative | 144,135,000USD | 94,329,000USD | 42,538,000USD | 45,473,000USD | 40,312,000USD | 55,343,000USD | 50,523,000USD | 42,001,000USD |
| Unclassified Operating Expenses | 38,522,000USD | -3,907,000USD | 1,916,000USD | — | — | — | — | — |
| Total Operating Expenses | 249,005,000USD | 136,315,000USD | 127,513,000USD | 146,995,000USD | 152,591,000USD | 305,785,000USD | 307,367,000USD | 233,797,000USD |
| Operating Income | 38,801,000USD | 72,587,000USD | 8,678,000USD | -146,960,000USD | -152,498,000USD | -305,765,000USD | -307,357,000USD | -233,697,000USD |
| Interest Income | 8,053,000USD | 12,615,000USD | 5,386,000USD | — | — | — | — | — |
| Interest Expense | 13,830,000USD | 37,981,000USD | 25,161,000USD | 21,630,000USD | 17,377,000USD | 2,339,000USD | 3,408,000USD | 1,511,000USD |
| Net Interest Income | -29,976,000USD | -25,366,000USD | -19,707,000USD | — | — | — | — | — |
| Income Before Tax | 1,407,000USD | 30,518,000USD | -10,377,000USD | -169,774,000USD | -170,560,000USD | -303,037,000USD | -293,187,000USD | -230,543,000USD |
| Income Tax Expense | -4,456,000USD | 2,930,000USD | 1,561,000USD | -408,000USD | 738,000USD | 2,000USD | 3,000USD | 5,000USD |
| Tax Provision | -4,456,000USD | 2,930,000USD | 1,561,000USD | — | — | — | — | — |
| Net Income | 5,863,000USD | 27,588,000USD | -11,938,000USD | -169,366,000USD | -170,560,000USD | -303,039,000USD | -293,190,000USD | -230,548,000USD |
| Net Income From Continuing Ops | 5,863,000USD | 27,588,000USD | -31,286,000USD | -169,366,000USD | — | — | — | — |
| Ebit | 15,237,000USD | 68,499,000USD | 10,594,000USD | -148,144,000USD | -153,183,000USD | -300,698,000USD | -289,779,000USD | -233,697,000USD |
| Ebitda | 27,521,000USD | 77,467,000USD | 15,129,000USD | -133,742,000USD | -135,859,000USD | -288,411,000USD | -280,806,000USD | -225,180,000USD |
| Depreciation And Amortization | 12,284,000USD | 8,968,000USD | 4,535,000USD | 14,402,000USD | 17,324,000USD | 12,287,000USD | 8,973,000USD | 8,517,000USD |
| Reconciled Depreciation | 12,284,000USD | 9,039,000USD | 8,436,000USD | — | — | — | — | — |
| Total Other Income Expense Net | -37,394,000USD | -42,069,000USD | -19,055,000USD | -22,814,000USD | -18,062,000USD | 2,728,000USD | 14,170,000USD | 3,154,000USD |
| Selling And Marketing Expenses | — | — | 51,776,000USD | — | — | — | — | — |
| Non Operating Income Net Other | — | — | — | -1,184,000USD | — | — | — | — |
| Net Income Applicable To Common Shares | — | — | — | -169,366,000USD | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Quarterly
| Metric | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD | Q4 20232023-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 82,130,000USD | 76,527,000USD | 78,354,000USD | 76,776,000USD | 70,079,000USD | 72,386,000USD | 66,263,000USD | 58,472,000USD |
| Cost Of Revenue | 20,203,000USD | 20,568,000USD | 17,516,000USD | 19,604,000USD | 18,023,000USD | 20,377,000USD | 18,598,000USD | 18,067,000USD |
| Gross Profit | 61,927,000USD | 55,959,000USD | 60,838,000USD | 57,172,000USD | 52,056,000USD | 52,009,000USD | 47,665,000USD | 40,405,000USD |
| Research Development | 14,063,000USD | 13,675,000USD | 11,022,000USD | 11,138,000USD | 12,926,000USD | 11,816,000USD | 10,013,000USD | 9,236,000USD |
| Selling General Administrative | 14,394,000USD | 31,622,000USD | 25,014,000USD | 34,168,000USD | 10,823,000USD | 12,617,000USD | 10,728,000USD | 9,511,000USD |
| Selling And Marketing Expenses | 14,694,000USD | — | — | — | 13,093,000USD | 11,495,000USD | — | 11,024,000USD |
| Total Operating Expenses | 43,151,000USD | 50,660,000USD | 38,545,000USD | 30,677,000USD | 39,296,000USD | 35,399,000USD | 30,943,000USD | 32,547,000USD |
| Operating Income | 18,776,000USD | 5,299,000USD | 22,293,000USD | 26,495,000USD | 12,760,000USD | 16,610,000USD | 16,722,000USD | 7,858,000USD |
| Interest Income | 2,628,000USD | 1,832,000USD | 1,956,000USD | 2,825,000USD | 3,179,000USD | 3,177,000USD | 3,434,000USD | 1,725,000USD |
| Interest Expense | 7,334,000USD | 6,191,000USD | 10,632,000USD | 7,481,000USD | 8,360,000USD | 12,878,000USD | 9,262,000USD | 5,355,000USD |
| Net Interest Income | -4,706,000USD | -4,359,000USD | -8,676,000USD | -4,656,000USD | -5,181,000USD | -9,701,000USD | -5,828,000USD | -3,630,000USD |
| Income Before Tax | 7,781,000USD | 940,000USD | 13,617,000USD | 8,445,000USD | 12,870,000USD | -1,691,000USD | 10,894,000USD | 2,962,000USD |
| Income Tax Expense | -204,000USD | 272,000USD | 459,000USD | 1,023,000USD | 1,320,000USD | 323,000USD | 264,000USD | 1,561,000USD |
| Tax Provision | -204,000USD | 272,000USD | 459,000USD | 1,023,000USD | 1,320,000USD | 323,000USD | 264,000USD | 1,561,000USD |
| Net Income | 7,985,000USD | 668,000USD | 13,158,000USD | 7,422,000USD | 11,550,000USD | -2,014,000USD | 10,630,000USD | 1,401,000USD |
| Net Income From Continuing Ops | 7,985,000USD | 668,000USD | 13,158,000USD | 7,422,000USD | 11,550,000USD | -2,014,000USD | 10,630,000USD | 1,401,000USD |
| Ebit | 15,115,000USD | 7,131,000USD | 24,249,000USD | 15,926,000USD | 21,230,000USD | 11,187,000USD | 20,156,000USD | 8,317,000USD |
| Ebitda | 17,866,000USD | 9,749,000USD | 26,899,000USD | 18,614,000USD | 23,842,000USD | 13,237,000USD | 21,845,000USD | 9,865,000USD |
| Depreciation And Amortization | 2,751,000USD | 2,618,000USD | 2,650,000USD | 2,688,000USD | 2,612,000USD | 2,050,000USD | 1,689,000USD | 1,548,000USD |
| Reconciled Depreciation | 2,801,000USD | 2,618,000USD | 2,650,000USD | 2,688,000USD | 2,612,000USD | 2,050,000USD | 1,689,000USD | 1,548,000USD |
| Total Other Income Expense Net | -10,995,000USD | -4,359,000USD | -8,676,000USD | -18,050,000USD | 110,000USD | -18,301,000USD | -5,828,000USD | -4,896,000USD |
| Unclassified Operating Expenses | — | 5,363,000USD | 2,509,000USD | -14,629,000USD | 2,454,000USD | — | 10,202,000USD | 2,776,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 744,403,000USD | 792,182,000USD | 494,640,000USD | 411,697,000USD | 410,141,000USD | 393,843,000USD | 464,200,000USD | 443,836,000USD |
| Intangible Assets | 320,332,000USD | 5,072,000USD | 5,120,000USD | 5,169,000USD | 5,217,000USD | 5,265,000USD | 5,313,000USD | 1,033,000USD |
| Other Current Assets | 39,396,000USD | 46,553,000USD | 52,946,999USD | 44,409,000USD | 34,404,000USD | 31,360,000USD | 31,229,000USD | 30,080,000USD |
| Total Liab | 803,598,000USD | 843,204,000USD | 539,192,000USD | 466,739,000USD | 468,759,000USD | 472,659,000USD | 674,126,000USD | 669,616,000USD |
| Total Stockholder Equity | -59,195,000USD | -51,022,000USD | -44,552,000USD | -55,042,000USD | -58,618,000USD | -78,816,000USD | -209,926,000USD | -225,780,000USD |
| Other Current Liab | 94,008,000USD | 97,428,000USD | 42,783,000USD | 54,449,000USD | 63,030,000USD | 49,465,000USD | 57,632,000USD | 62,612,000USD |
| Common Stock | 3,089,000USD | 3,078,000USD | 3,070,000USD | 3,063,000USD | 3,039,000USD | 3,029,000USD | 2,753,000USD | 2,740,000USD |
| Capital Stock | 3,089,000USD | 3,078,000USD | 3,070,000USD | 3,063,000USD | 3,039,000USD | 3,029,000USD | 2,753,000USD | 2,740,000USD |
| Retained Earnings | -3,212,575,000USD | -3,195,956,000USD | -3,180,008,000USD | -3,187,993,000USD | -3,188,661,000USD | -3,201,819,000USD | -3,209,241,000USD | -3,220,791,000USD |
| Good Will | 67,595,000USD | 67,595,000USD | 1,931,000USD | 1,931,000USD | 1,931,000USD | 1,931,000USD | 1,931,000USD | 1,931,000USD |
| Cash | 52,834,000USD | 74,882,000USD | 127,392,000USD | 57,006,000USD | 47,312,000USD | 46,339,000USD | 62,373,000USD | 96,643,000USD |
| Cash And Short Term Investments | 133,860,999USD | 171,346,000USD | 260,035,000USD | 178,985,000USD | 181,541,000USD | 197,256,000USD | 251,588,000USD | 247,761,000USD |
| Total Current Assets | 251,160,000USD | 291,579,000USD | 358,837,000USD | 279,027,000USD | 273,737,000USD | 268,306,000USD | 327,664,000USD | 325,940,000USD |
| Total Current Liabilities | 134,561,000USD | 171,031,000USD | 109,130,000USD | 111,826,000USD | 115,937,000USD | 81,837,000USD | 72,101,000USD | 80,012,000USD |
| Current Deferred Revenue | 11,525,000USD | 15,331,000USD | 10,123,000USD | 10,954,000USD | 11,757,000USD | 12,407,000USD | 6,518,000USD | 7,420,000USD |
| Net Debt | 383,840,000USD | 398,501,000USD | 98,559,000USD | -10,184,000USD | -62,000USD | 110,881,000USD | 177,906,000USD | 134,390,000USD |
| Short Term Debt | 12,884,000USD | 49,238,000USD | 48,955,000USD | 36,166,000USD | 36,109,000USD | 13,124,000USD | — | 13,099,000USD |
| Short Long Term Debt Total | 436,674,000USD | 473,383,000USD | 225,951,000USD | 46,822,000USD | 47,250,000USD | 157,220,000USD | 240,279,000USD | 231,033,000USD |
| Long Term Debt | 318,722,000USD | 318,361,000USD | 73,428,000USD | — | — | 36,051,000USD | 227,941,000USD | 227,577,000USD |
| Long Term Investments | 0USD | 5,012,000USD | 26,226,000USD | 22,240,000USD | 16,681,000USD | 5,482,000USD | 16,796,000USD | 13,398,000USD |
| Short Term Investments | 81,027,000USD | 96,464,000USD | 132,643,000USD | 121,979,000USD | 134,229,000USD | 150,917,000USD | 189,215,000USD | 151,118,000USD |
| Net Receivables | 28,737,000USD | 38,367,000USD | 18,883,000USD | 27,142,000USD | 28,900,000USD | 11,804,000USD | 18,184,000USD | 23,346,000USD |
| Inventory | 49,166,000USD | 35,313,000USD | 26,972,000USD | 28,491,000USD | 28,892,000USD | 27,886,000USD | 26,663,000USD | 24,753,000USD |
| Accounts Payable | 16,143,999USD | 9,034,000USD | 7,269,000USD | 10,257,000USD | 5,041,000USD | 6,792,000USD | 6,444,000USD | 9,556,000USD |
| Property Plant Equipment Net | 93,845,000USD | 82,423,000USD | 93,946,000USD | 82,965,000USD | 83,781,000USD | 85,365,000USD | 85,339,000USD | 85,144,000USD |
| Property Plant Equipment Gross | 198,345,000USD | 196,336,000USD | 195,380,000USD | 193,680,000USD | 192,456,000USD | 192,041,000USD | 191,973,000USD | 189,679,000USD |
| Accumulated Other Comprehensive Income | -4,000USD | 115,000USD | 137,000USD | 1,257,000USD | 1,174,000USD | 1,109,000USD | 588,000USD | — |
| Common Stock Shares Outstanding | 308,267,000shares | 314,112,000shares | 311,638,000shares | 311,484,000shares | 320,897,000shares | 290,631,000shares | 284,693,000shares | 273,056,000shares |
| Non Current Assets Total | 493,243,000USD | 500,603,000USD | 135,803,000USD | 132,670,000USD | 136,404,000USD | 125,537,000USD | 136,536,000USD | 117,896,000USD |
| Non Current Liabilities Total | 669,036,999USD | 672,173,000USD | 430,062,000USD | 354,913,000USD | 352,822,000USD | 390,822,000USD | 602,025,000USD | 589,604,000USD |
| Non Current Liabilities Other | 301,129,000USD | 303,146,000USD | 298,182,000USD | 298,785,000USD | 294,321,000USD | 291,966,000USD | 296,596,000USD | 292,455,000USD |
| Non Currrent Assets Other | 10,724,000USD | 340,501,000USD | 7,837,000USD | 20,365,000USD | 28,794,000USD | 27,494,000USD | 27,157,000USD | 16,390,000USD |
| Net Working Capital | 116,599,000USD | 120,548,000USD | 249,707,000USD | 167,201,000USD | 157,800,000USD | 186,469,000USD | 255,563,000USD | 245,928,000USD |
| Unclassified Non Current Liabilities | 49,185,999USD | 50,666,000USD | 58,452,000USD | 56,128,000USD | 58,501,000USD | 62,805,000USD | 77,488,000USD | 69,572,000USD |
| Unclassified Equity | 3,147,206,000USD | 3,138,663,000USD | 3,129,179,000USD | 3,125,568,000USD | 3,122,791,000USD | 3,115,836,000USD | 2,993,221,000USD | 2,989,531,000USD |
| Short Long Term Debt | — | 36,280,000USD | 36,224,000USD | 36,166,000USD | 36,109,000USD | — | — | — |
| Unclassified Current Liabilities | — | -36,280,000USD | -36,224,000USD | -36,166,000USD | -36,109,000USD | — | 1,507,000USD | -12,675,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 792,182,000USD | 393,843,000USD | 475,198,000USD | 295,282,000USD | 321,161,000USD | 108,608,000USD | 93,725,000USD | 107,705,000USD |
| Intangible Assets | 5,072,000USD | 5,265,000USD | 1,073,000USD | 1,153,000USD | — | — | — | — |
| Other Current Assets | 46,553,000USD | 31,360,000USD | 34,848,000USD | 25,477,000USD | 3,482,000USD | 3,280,000USD | 3,205,000USD | 3,083,000USD |
| Total Liab | 843,204,000USD | 472,659,000USD | 721,366,000USD | 545,820,000USD | 530,510,000USD | 289,027,000USD | 284,251,000USD | 282,787,000USD |
| Total Stockholder Equity | -51,022,000USD | -78,816,000USD | -246,168,000USD | -250,538,000USD | -209,349,000USD | -180,419,000USD | -190,526,000USD | -175,082,000USD |
| Other Current Liab | 97,428,000USD | 62,589,000USD | 63,899,000USD | 44,946,000USD | 33,589,000USD | 30,787,000USD | 23,298,000USD | 58,564,000USD |
| Common Stock | 3,078,000USD | 3,029,000USD | 2,700,000USD | 2,638,000USD | 2,515,000USD | 2,421,000USD | 2,118,000USD | 1,870,000USD |
| Capital Stock | 3,078,000USD | 3,029,000USD | 2,700,000USD | 2,638,000USD | 2,515,000USD | 2,421,000USD | 2,118,000USD | 1,870,000USD |
| Retained Earnings | -3,195,956,000USD | -3,201,819,000USD | -3,229,407,000USD | -3,217,469,000USD | -3,130,069,000USD | -3,049,143,000USD | -2,991,903,000USD | -2,940,000,000USD |
| Good Will | 67,595,000USD | 1,931,000USD | 1,931,000USD | 2,428,000USD | 0USD | — | — | — |
| Cash | 74,882,000USD | 46,339,000USD | 238,480,000USD | 69,767,000USD | 124,184,000USD | 67,005,000USD | 29,906,000USD | 71,157,000USD |
| Cash And Short Term Investments | 171,346,000USD | 197,256,000USD | 295,099,000USD | 170,846,000USD | 204,116,000USD | 67,005,000USD | 49,884,000USD | 71,157,000USD |
| Total Current Assets | 291,579,000USD | 268,306,000USD | 373,393,000USD | 234,896,000USD | 219,489,000USD | 79,476,000USD | 60,757,000USD | 81,854,000USD |
| Total Current Liabilities | 171,031,000USD | 81,837,000USD | 104,125,000USD | 67,296,000USD | 48,349,000USD | 73,705,000USD | 65,618,000USD | 75,241,000USD |
| Current Deferred Revenue | 15,331,000USD | 12,407,000USD | 9,085,000USD | 1,733,000USD | 827,000USD | 33,275,000USD | 32,503,000USD | 50,872,000USD |
| Net Debt | 398,501,000USD | 1,357,000USD | 34,144,000USD | 218,631,000USD | 165,035,000USD | 56,432,000USD | 91,507,000USD | 31,329,000USD |
| Short Term Debt | 49,238,000USD | 13,124,000USD | 20,000,000USD | 9,565,000USD | 6,977,000USD | 4,061,000USD | 5,028,000USD | 11,298,000USD |
| Short Long Term Debt | 36,280,000USD | — | 20,000,000USD | 9,565,000USD | 6,977,000USD | 4,061,000USD | 5,028,000USD | 11,298,000USD |
| Short Long Term Debt Total | 473,383,000USD | 47,696,000USD | 272,624,000USD | 288,398,000USD | 289,219,000USD | 123,437,000USD | 121,413,000USD | 102,486,000USD |
| Long Term Debt | 318,361,000USD | 36,051,000USD | 248,699,000USD | 368,002,000USD | 223,944,000USD | 5,000,000USD | 5,000,000USD | 91,188,000USD |
| Long Term Investments | 5,012,000USD | 5,482,000USD | 7,155,000USD | 1,961,000USD | 56,619,000USD | 0USD | — | — |
| Short Term Investments | 96,464,000USD | 150,917,000USD | 56,619,000USD | 101,079,000USD | 79,932,000USD | 0USD | 19,978,000USD | — |
| Net Receivables | 38,367,000USD | 11,804,000USD | 14,901,000USD | 16,801,000USD | 4,739,000USD | 4,218,000USD | 3,513,000USD | 4,017,000USD |
| Inventory | 35,313,000USD | 27,886,000USD | 28,545,000USD | 21,772,000USD | 7,152,000USD | 4,973,000USD | 4,155,000USD | 3,597,000USD |
| Accounts Payable | 9,034,000USD | 6,792,000USD | 9,580,000USD | 11,052,000USD | 6,956,000USD | 5,582,000USD | 4,789,000USD | 5,379,000USD |
| Property Plant Equipment Net | 82,423,000USD | 85,365,000USD | 84,220,000USD | 45,126,000USD | 36,612,000USD | 25,867,000USD | 26,778,000USD | 25,602,000USD |
| Property Plant Equipment Gross | 196,336,000USD | 192,041,000USD | 185,756,000USD | 143,686,000USD | 134,273,000USD | 25,867,000USD | 26,778,000USD | 25,602,000USD |
| Accumulated Other Comprehensive Income | 115,000USD | 1,109,000USD | — | — | — | — | -19,000USD | -19,000USD |
| Common Stock Shares Outstanding | 314,112,000shares | 283,844,000shares | 267,014,000shares | 257,091,999shares | 249,244,000shares | 222,585,000shares | 195,584,000shares | 144,136,000shares |
| Non Current Assets Total | 500,603,000USD | 125,537,000USD | 101,805,000USD | 60,386,000USD | 101,672,000USD | 29,132,000USD | 32,968,000USD | 25,851,000USD |
| Non Current Liabilities Total | 672,173,000USD | 390,822,000USD | 617,241,000USD | 478,524,000USD | 482,161,000USD | 215,322,000USD | 218,633,000USD | 207,546,000USD |
| Non Current Liabilities Other | 303,146,000USD | 291,966,000USD | 294,767,000USD | 67,440,000USD | 258,217,000USD | 210,322,000USD | 213,633,000USD | 98,843,000USD |
| Non Currrent Assets Other | 340,501,000USD | 27,494,000USD | 7,426,000USD | 9,718,000USD | 8,441,000USD | 3,265,000USD | 6,190,000USD | 249,000USD |
| Net Working Capital | 120,548,000USD | 186,469,000USD | 269,268,000USD | 167,600,000USD | 171,395,000USD | 5,771,000USD | -4,861,000USD | 6,613,000USD |
| Unclassified Current Liabilities | -36,280,000USD | -13,075,000USD | -18,439,000USD | -9,565,000USD | -6,977,000USD | -4,061,000USD | -5,028,000USD | -62,170,000USD |
| Unclassified Non Current Liabilities | 50,666,000USD | 62,805,000USD | 73,775,000USD | -62,097,000USD | -106,394,000USD | -95,946,000USD | -102,248,000USD | -98,843,000USD |
| Unclassified Equity | 3,138,663,000USD | 3,115,836,000USD | 2,977,839,000USD | 2,961,655,000USD | 2,915,690,000USD | 2,863,882,000USD | 2,797,160,000USD | 2,761,197,000USD |
| Other Liab | — | — | — | 105,179,000USD | 106,394,000USD | 95,946,000USD | 102,248,000USD | 116,358,000USD |
| Other Assets | — | — | — | 9,718,000USD | 5,186,000USD | 3,265,000USD | 2,180,000USD | 249,000USD |
| Net Tangible Assets | — | — | — | -254,119,000USD | -209,349,000USD | -180,419,000USD | -190,526,000USD | -175,082,000USD |
| Unclassified Non Current Assets | — | — | — | -9,718,000USD | -5,186,000USD | -3,265,000USD | -2,180,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -16,619,000USD | -15,948,000USD | 7,985,000USD | 668,000USD | 13,158,000USD | 7,422,000USD | 11,550,000USD | -2,014,000USD |
| Depreciation | 6,382,000USD | 4,215,000USD | 2,751,000USD | 2,618,000USD | 2,650,000USD | 2,677,000USD | 2,612,000USD | 2,050,000USD |
| Stock Based Compensation | 6,455,000USD | 6,972,000USD | 4,318,000USD | 7,520,000USD | 5,385,000USD | 5,818,000USD | 5,227,000USD | 6,428,000USD |
| Other Non Cash Items | 9,568,000USD | 73,909,000USD | 13,551,000USD | 9,657,000USD | 2,742,000USD | 10,930,000USD | -5,062,000USD | 7,785,000USD |
| Change To Account Receivables | 10,290,000USD | 817,000USD | 9,759,000USD | 1,758,000USD | -17,096,000USD | 6,380,000USD | 5,162,000USD | -3,434,000USD |
| Change To Inventory | -14,928,000USD | -10,597,000USD | -1,758,000USD | -4,191,000USD | -1,472,000USD | -3,169,000USD | -2,201,000USD | 1,100,000USD |
| Change In Working Capital | -4,975,000USD | -72,137,000USD | -801,000USD | -11,513,000USD | -30,312,000USD | -4,203,000USD | -4,996,000USD | -10,416,000USD |
| Total Cash From Operating Activities | -5,644,000USD | -7,958,000USD | 23,486,000USD | 8,950,000USD | -6,377,000USD | 22,644,000USD | 9,331,000USD | 3,833,000USD |
| Capital Expenditures | -1,880,000USD | -1,994,000USD | -1,125,000USD | -1,117,000USD | -330,000USD | -2,896,000USD | -1,417,000USD | -2,972,000USD |
| Free Cash Flow | -7,524,000USD | -9,952,000USD | 22,361,000USD | 7,833,000USD | -6,707,000USD | 19,748,000USD | 7,914,000USD | 861,000USD |
| Investments | 20,605,000USD | 57,773,000USD | -25,058,000USD | 6,256,000USD | 5,962,000USD | 48,224,000USD | -41,256,000USD | -55,180,000USD |
| Total Cashflows From Investing Activities | 18,725,000USD | -291,963,000USD | -25,058,000USD | 6,256,000USD | 5,962,000USD | 48,224,000USD | -41,256,000USD | -55,180,000USD |
| Net Borrowings | -35,502,000USD | 250,000,000USD | 75,000,000USD | 0USD | 0USD | -87,694,000USD | 0USD | — |
| Total Cash From Financing Activities | -35,127,000USD | 247,413,000USD | 71,960,000USD | -5,510,000USD | 1,390,000USD | -86,900,000USD | -2,342,000USD | -44,550,000USD |
| Issuance Of Capital Stock | 105,000USD | — | — | — | 1,590,000USD | 0USD | 0USD | -1,361,000USD |
| Change In Cash | -22,048,000USD | -52,508,000USD | 70,386,000USD | 9,696,000USD | 975,000USD | -16,032,000USD | -34,267,000USD | -95,897,000USD |
| Begin Period Cash Flow | 74,882,000USD | 128,135,000USD | 57,006,000USD | 48,051,000USD | 47,076,000USD | 63,108,000USD | 97,375,000USD | 193,272,000USD |
| End Period Cash Flow | 52,834,000USD | 75,627,000USD | 127,392,000USD | 57,747,000USD | 48,051,000USD | 47,076,000USD | 63,108,000USD | 97,375,000USD |
| Other Cashflows From Financing Activities | -35,406,000USD | -3,241,000USD | -2,451,000USD | -6,622,000USD | 1,590,000USD | 3,114,000USD | -752,000USD | -2,715,000USD |
| Unclassified Operating Cash Flow | -6,455,000USD | -4,969,000USD | -4,318,000USD | — | — | — | — | — |
| Unclassified Financing Cash Flow | 35,676,000USD | — | — | 1,112,000USD | -1,790,000USD | -2,320,000USD | — | -37,168,000USD |
| Unclassified Investing Cash Flow | — | -347,742,000USD | 11,125,000USD | 1,117,000USD | — | 2,896,000USD | 41,256,000USD | 55,180,000USD |
| Other Cashflows From Investing Activities | — | — | -10,000,000USD | — | — | — | -39,839,000USD | -52,208,000USD |
| Sale Purchase Of Stock | — | — | — | — | — | — | -1,511,000USD | -4,667,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 5,863,000USD | 27,588,000USD | -11,938,000USD | -87,400,000USD | -80,926,000USD | -57,240,000USD | -51,903,000USD | -86,975,000USD |
| Depreciation | 12,284,000USD | 9,039,000USD | 5,801,000USD | 6,287,000USD | 5,473,000USD | 3,326,000USD | 2,154,000USD | 1,700,000USD |
| Stock Based Compensation | 24,195,000USD | 21,358,000USD | 17,649,000USD | 13,447,000USD | 12,200,000USD | 6,511,000USD | 6,203,000USD | 6,857,000USD |
| Other Non Cash Items | 67,230,000USD | 20,999,000USD | 7,956,000USD | 24,470,000USD | 6,633,000USD | 18,400,000USD | -28,003,000USD | 5,705,000USD |
| Change To Account Receivables | -4,762,000USD | 2,652,000USD | 2,345,000USD | -11,807,000USD | -776,000USD | -705,000USD | 504,000USD | -1,339,000USD |
| Change To Inventory | 10,397,000USD | -3,196,000USD | 4,574,000USD | -5,670,000USD | -4,081,000USD | -1,314,000USD | -558,000USD | -3,152,000USD |
| Change In Working Capital | -86,348,000USD | -36,473,000USD | 14,626,000USD | -24,054,000USD | -17,730,000USD | -9,780,000USD | -12,360,000USD | 36,682,000USD |
| Total Cash From Operating Activities | 18,255,000USD | 42,511,000USD | 34,094,000USD | -80,697,000USD | -61,709,000USD | -28,128,000USD | -88,483,000USD | -37,731,000USD |
| Capital Expenditures | -4,566,000USD | -9,693,000USD | -42,441,000USD | -7,589,000USD | -11,466,000USD | -4,784,000USD | -2,565,000USD | -354,000USD |
| Free Cash Flow | 13,689,000USD | 32,818,000USD | -8,347,000USD | -88,286,000USD | -73,175,000USD | -32,912,000USD | -91,048,000USD | -38,085,000USD |
| Investments | 57,505,000USD | -96,649,000USD | 20,917,000USD | 4,874,000USD | -137,071,000USD | 20,000,000USD | -20,278,000USD | -234,000USD |
| Total Cashflows From Investing Activities | -304,803,000USD | -96,649,000USD | -1,988,000USD | 4,874,000USD | -151,537,000USD | 15,216,000USD | -22,843,000USD | -234,000USD |
| Net Borrowings | 325,000,000USD | -133,168,000USD | -6,667,000USD | -18,000USD | 177,681,000USD | 14,873,000USD | 63,696,000USD | -6,610,000USD |
| Total Cash From Financing Activities | 315,099,000USD | -137,266,000USD | 136,607,000USD | 21,406,000USD | 270,267,000USD | 49,853,000USD | 69,864,000USD | 61,294,000USD |
| Issuance Of Capital Stock | 0USD | 0USD | 7,278,000USD | 19,790,000USD | 1,992,000USD | 23,665,000USD | 3,199,000USD | 70,519,000USD |
| Change In Cash | 28,551,000USD | -191,404,000USD | 168,713,000USD | -54,417,000USD | 57,021,000USD | 36,941,000USD | -41,462,000USD | 23,329,000USD |
| Begin Period Cash Flow | 47,076,000USD | 238,480,000USD | 69,767,000USD | 124,184,000USD | 67,163,000USD | 30,222,000USD | 71,684,000USD | 48,355,000USD |
| End Period Cash Flow | 75,627,000USD | 47,076,000USD | 238,480,000USD | 69,767,000USD | 124,184,000USD | 67,163,000USD | 30,222,000USD | 71,684,000USD |
| Other Cashflows From Investing Activities | -16,409,000USD | 128,707,000USD | 382,000USD | 32,804,000USD | 56,060,000USD | 20,000,000USD | -20,278,000USD | 120,000USD |
| Other Cashflows From Financing Activities | -11,893,000USD | 1,989,000USD | 136,576,000USD | -62,000USD | -12,698,000USD | 11,315,000USD | 122,930,000USD | -4,225,000USD |
| Unclassified Operating Cash Flow | -4,969,000USD | — | — | -13,447,000USD | 12,641,000USD | 10,655,000USD | -4,574,000USD | -1,700,000USD |
| Unclassified Investing Cash Flow | -341,333,000USD | -119,014,000USD | 19,154,000USD | -25,215,000USD | -59,060,000USD | -20,000,000USD | 20,278,000USD | — |
| Unclassified Financing Cash Flow | — | -6,087,000USD | 16,860,000USD | 2,077,000USD | 106,280,000USD | 37,854,000USD | -116,762,000USD | 4,232,000USD |
| Sale Purchase Of Stock | — | — | -10,162,000USD | 19,409,000USD | -498,000USD | 684,000USD | 656,000USD | 67,897,000USD |
| Change To Liabilities | — | — | — | -1,577,000USD | 15,138,000USD | 4,139,000USD | 2,905,000USD | 644,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -54,417,000USD | 57,021,000USD | 36,941,000USD | -41,462,000USD | 23,329,000USD |
| Dividends Paid | — | — | — | — | -498,000USD | -14,873,000USD | -656,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2022Quarterly · 2022-03-31 | Product | License And Service | 2,166,000 | USD | 0001564590-22-018245 |
| Q1 2022Quarterly · 2022-03-31 | Product | Product | 9,826,000 | USD | 0001564590-22-018245 |
| Q4 2021Quarterly · 2021-12-31 | Product | License And Service | 1,175,000 | USD | Legacy provider |
| Q4 2021Quarterly · 2021-12-31 | Product | Product | 11,340,000 | USD | Legacy provider |
| FY 2021Yearly · 2021-12-31 | Product | License And Service | 36,274,000 | USD | 0000950170-24-021423 |
| FY 2021Yearly · 2021-12-31 | Product | Product Revenue | 39,435,000 | USD | 0000950170-24-021423 |
| Q3 2021Quarterly · 2021-09-30 | Product | License And Service | 12,458,000 | USD | 0001564590-22-036933 |
| Q3 2021Quarterly · 2021-09-30 | Product | Product Sales | 9,753,000 | USD | 0001564590-22-036933 |
| Q2 2021Quarterly · 2021-06-30 | Product | License And Service | 13,304,000 | USD | 0001564590-22-028753 |
| Q2 2021Quarterly · 2021-06-30 | Product | Product Sales | 9,976,000 | USD | 0001564590-22-028753 |
| Q1 2021Quarterly · 2021-03-31 | Product | License And Service | 9,337,000 | USD | 0001564590-22-018245 |
| Q1 2021Quarterly · 2021-03-31 | Product | Product | 8,099,000 | USD | 0001564590-22-018245 |
| Q4 2020Quarterly · 2020-12-31 | Product | License And Service | 8,379,000 | USD | Legacy provider |
| Q4 2020Quarterly · 2020-12-31 | Product | Product | 10,064,000 | USD | Legacy provider |
| FY 2020Yearly · 2020-12-31 | Product | License And Service | 32,820,000 | USD | 0001564590-23-002309 |
| FY 2020Yearly · 2020-12-31 | Product | Product Sales | 32,324,000 | USD | 0001564590-23-002309 |
| Q3 2020Quarterly · 2020-09-30 | Product | License And Service | 8,077,000 | USD | 0001564590-21-055727 |
| Q3 2020Quarterly · 2020-09-30 | Product | Product | 7,275,000 | USD | 0001564590-21-055727 |
| Q2 2020Quarterly · 2020-06-30 | Product | License And Service | 8,129,000 | USD | 0001564590-21-043433 |
| Q2 2020Quarterly · 2020-06-30 | Product | Product | 6,985,000 | USD | 0001564590-21-043433 |
| FY 2019Yearly · 2019-12-31 | Product | License And Service | 37,734,000 | USD | 0001564590-21-008440 |
| FY 2019Yearly · 2019-12-31 | Product | Product | 25,304,000 | USD | 0001564590-21-008440 |
| FY 2018Yearly · 2018-12-31 | Product | License And Service | 10,583,000 | USD | 0001564590-20-006198 |
| FY 2018Yearly · 2018-12-31 | Product | Product | 17,276,000 | USD | 0001564590-20-006198 |
| FY 2016Yearly · 2016-12-31 | Product | License And Service | 171,965,000 | USD | 0001564590-19-004263 |
| FY 2016Yearly · 2016-12-31 | Product | Product | 1,895,000 | USD | 0001564590-19-004263 |
| FY 2016Yearly · 2016-12-31 | Product | Product And Service Other | 898,000 | USD | 0001564590-19-004263 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.